A 51 year old female patient has been receiving doxorubicin Adriamycin for

A 51 year old female patient has been receiving

This is a preview. Sign up to view the full content.

Question 13 A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast cancer. Her medical record indicates she has cardiomyopathy and a cumulative dose of 300 mg/m2 of doxorubicin. Which of the following measures would help limit the severity of the cardiomyopathy in this patient? A reduced dose Meticulous monitoring during drug administration The use of dexrazoxane in conjunction with doxorubicin A single large dose instead of multiple doses
Image of page 4
Image of page 5

You've reached the end of your free preview.

Want to read all 21 pages?

  • Summer '15

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture